AP
Shares of Merck fell 77 cents, or 2.6 percent, to $28.91 in early trading on the New York Stock Exchange.
Authors of a study funded by Vioxx maker Merck & Co. failed to disclose in a report published in the New England Journal of Medicine in 2000 that three additional patients in a clinical study suffered heart attacks while using the now-withdrawn painkiller, the journal wrote in an editorial released Thursday.
More...
|